Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 9953 - 9960 of 12089 results
On the Seventh Day of Privacy, federal agencies gave to me.....
December 17, 2014| Blog| Viewpoint
Enactment Imminent for Section 529A Tax-Exempt Savings Programs for Disabled Beneficiaries
December 17, 2014| Blog| Viewpoint
The Affordable Care Act—Countdown to Compliance for Employers, Week 2: Explaining the Look-Back Measurement Method to Employees
December 16, 2014| Blog| Viewpoint
EEOC's Attempt to Limit Reach of Severance Agreements Hits Roadblock… Again
December 16, 2014| Blog| Viewpoint
Supreme Court Finds that Post-Shift Employee Security Screenings Noncompensable Activity Under the Fair Labor Standards Act
December 16, 2014| Blog| Viewpoint
On the Sixth Day of Privacy, the hackers gave to Sony......
December 16, 2014| Blog| Viewpoint
Back at it Again: NLRB Invalidates Employer’s “Overbroad” Solicitation Rule
December 15, 2014| Blog| Viewpoint
News & Press Releases
Mintz advised the creators of Morbid, one of the top-charting true crime podcasts, in a multi-year agreement to move to SiriusXM from Wondery. The deal gives SiriusXM exclusive advertising rights for the audio and video formats of the podcast.
Mintz Advises CVC DIF in Acquisition of SBA Communications’ Canadian Tower Infrastructure Platform
August 06, 2025
Mintz advised CVC DIF, the dedicated infrastructure investment strategy of global private markets manager CVC, in its agreement to acquire SBA Communications’ Canadian wireless tower business, one of Canada’s leading independent owners and operators of wireless communications towers. The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions.
Mintz advised the underwriters in connection with a $69 million public offering by Larimar Therapeutics, Inc. of 21,562,500 shares of its common stock at a price to the public of $3.20 per share. The gross proceeds to Larimar from the offering were $69 million before deducting underwriting discounts and commissions and other offering expenses.
Events
Podcasts
Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|